Trials / Sponsors / Jingdong Zhang
Jingdong Zhang
Academic / Other · 1 registered clinical trial — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | SHR-1701 + Rivoceranib (± SHR-2554) in Advanced GC After First-Line Immunotherapy Failure Gastric Cancer (GC), Gastroesophageal Junction Adenocarcinoma | Phase 2 | 2026-01-01 |